Insider Selling: Amyris Inc (AMRS) Major Shareholder Sells $43,307.18 in Stock

Amyris Inc (NASDAQ:AMRS) major shareholder (Mauritius) Pte Ltd Maxwell sold 88,382 shares of the firm’s stock in a transaction on Monday, March 20th. The shares were sold at an average price of $0.49, for a total value of $43,307.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

(Mauritius) Pte Ltd Maxwell also recently made the following trade(s):

  • On Thursday, March 23rd, (Mauritius) Pte Ltd Maxwell sold 165,428 shares of Amyris stock. The shares were sold at an average price of $0.48, for a total transaction of $79,405.44.
  • On Tuesday, March 21st, (Mauritius) Pte Ltd Maxwell sold 223,073 shares of Amyris stock. The shares were sold at an average price of $0.48, for a total transaction of $107,075.04.
  • On Friday, March 17th, (Mauritius) Pte Ltd Maxwell sold 339,908 shares of Amyris stock. The shares were sold at an average price of $0.49, for a total transaction of $166,554.92.
  • On Wednesday, March 15th, (Mauritius) Pte Ltd Maxwell sold 270,374 shares of Amyris stock. The shares were sold at an average price of $0.46, for a total transaction of $124,372.04.
  • On Monday, March 13th, (Mauritius) Pte Ltd Maxwell sold 346,429 shares of Amyris stock. The shares were sold at an average price of $0.50, for a total transaction of $173,214.50.
  • On Thursday, March 9th, (Mauritius) Pte Ltd Maxwell sold 520,925 shares of Amyris stock. The shares were sold at an average price of $0.46, for a total transaction of $239,625.50.
  • On Tuesday, March 7th, (Mauritius) Pte Ltd Maxwell sold 852,224 shares of Amyris stock. The shares were sold at an average price of $0.45, for a total transaction of $383,500.80.
  • On Friday, March 3rd, (Mauritius) Pte Ltd Maxwell sold 868,589 shares of Amyris stock. The shares were sold at an average price of $0.49, for a total transaction of $425,608.61.
  • On Wednesday, March 1st, (Mauritius) Pte Ltd Maxwell sold 377,823 shares of Amyris stock. The shares were sold at an average price of $0.51, for a total transaction of $192,689.73.
  • On Monday, February 27th, (Mauritius) Pte Ltd Maxwell sold 287,706 shares of Amyris stock. The shares were sold at an average price of $0.52, for a total transaction of $149,607.12.

Shares of Amyris Inc (NASDAQ:AMRS) traded down 2.3838% during midday trading on Monday, hitting $0.4832. 103,838 shares of the company were exchanged. The firm’s market cap is $132.11 million. Amyris Inc has a one year low of $0.31 and a one year high of $1.43. The company’s 50 day moving average price is $0.51 and its 200 day moving average price is $0.67.

Amyris (NASDAQ:AMRS) last released its quarterly earnings data on Thursday, March 2nd. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by $0.03. The firm earned $32.20 million during the quarter, compared to analyst estimates of $38.72 million. The company’s revenue for the quarter was up 228.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.16) EPS. Equities analysts expect that Amyris Inc will post ($0.33) EPS for the current year.

Insider Buying and Selling by Quarter for Amyris (NASDAQ:AMRS)

COPYRIGHT VIOLATION WARNING: “Insider Selling: Amyris Inc (AMRS) Major Shareholder Sells $43,307.18 in Stock” was originally posted by Mideast Time and is owned by of Mideast Time. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.mideasttime.com/insider-selling-amyris-inc-amrs-major-shareholder-sells-43307-18-in-stock/1589232.html.

A number of brokerages recently weighed in on AMRS. HC Wainwright set a $4.00 price objective on shares of Amyris and gave the company a “buy” rating in a research note on Tuesday, January 10th. Zacks Investment Research upgraded shares of Amyris from a “sell” rating to a “hold” rating in a research note on Monday, January 16th. Finally, Rodman & Renshaw restated a “buy” rating and set a $4.00 price objective on shares of Amyris in a research note on Wednesday, January 11th.

A hedge fund recently raised its stake in Amyris stock. KBC Group NV boosted its position in shares of Amyris Inc (NASDAQ:AMRS) by 330.1% during the third quarter, according to its most recent filing with the SEC. The fund owned 329,101 shares of the company’s stock after buying an additional 252,589 shares during the period. KBC Group NV owned about 0.14% of Amyris worth $191,000 as of its most recent SEC filing. Institutional investors and hedge funds own 30.40% of the company’s stock.

About Amyris

Amyris, Inc is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels.

5 Day Chart for NASDAQ:AMRS

Receive News & Ratings for Amyris Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.